Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Insmed

Stocks To Watch: Insmed Sees RS Rating Jump To 93

Insmed sees its Relative Strength Rating reach the elite 90-plus level.

Investors Business Daily

Insmed Catapults Into Breakout Territory On A 'Home Run' For Its Rival To United, Liquidia

Insmed Catapults Into Breakout Territory On A 'Home Run' For Its Rival To United, Liquidia

Insmed stock catapulted into breakout territory early Tuesday after the biotech company hit a "home run" with its treatment for PAH.

Investors Business Daily

Meta Stock Leads 5 Names Near Buy Points As Market Bounces

Meta Stock Leads 5 Names Near Buy Points As Market Bounces

Meta leads five stocks near buy points as the market rallied Friday on Fed Chair Jerome Powell's speech.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

These Signs Show Which Stocks Are Having A Hidden Rally, Says Mark Minervini

"You're looking for those really, really great companies, especially if you're going for the bigger move," Minervini said.

Investors Business Daily

The Next Humira? Insmed Catapults 119% On Its 'Very Attractive' Opportunity In Lung Disease.

Insmed stock catapulted Tuesday after the biotech company's experimental lung disease treatment succeeded in a final-phase study.

Investors Business Daily

Insmed Is Making A Comeback — Why Shares Hit A Year High In Record Volume

Biotech stock Insmed rocketed Tuesday after the company said almost 44% of lung infection patients improved after receiving its drug.

Investors Business Daily

Insmed's Return On Capital Employed Overview

According to data from Benzinga Pro, during Q1, Insmed's (NASDAQ:INSM) reported sales totaled $53.11 million. Despite a 16.25% increase in earnings, the company posted a loss of $94.62 million.

inkl

Read news from The Economist, FT, and more,
with one subscription

Insmed: Q1 Earnings Insights

Insmed: Q1 Earnings Insights

Insmed (NASDAQ:INSM) reported its Q1 earnings results on Thursday, May 5, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

How To Attend Insmed Q1 2022 Earnings Conference Call

How To Attend Insmed Q1 2022 Earnings Conference Call

Insmed (NASDAQ:INSM) will host a conference call at 08:30 AM ET on May 5, 2022, to discuss Q1 2022 earnings results. How to Attend Insmed (INSM) Conference Call Follow this link to access the live webcast.

Benzinga's Top Ratings Upgrades, Downgrades For April 27, 2022

Benzinga's Top Ratings Upgrades, Downgrades For April 27, 2022

Insmed's Return On Capital Employed Insights

Insmed's Return On Capital Employed Insights

Insmed (NASDAQ:INSM) brought in sales totaling $56.12 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 0.23%, resulting in a loss of $112.98 million.

Insmed: Q4 Earnings Insights

Insmed: Q4 Earnings Insights

Insmed (NASDAQ:INSM) reported its Q4 earnings results on Thursday, February 17, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

People

Mark Zuckerberg

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

B of A Securities

JetBlue Airways

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play